Oral fructose absorption in obese children with non-alcoholic fatty liver disease

Pediatric Obesity

Volumn 10, Issue 3, 2015, Pages 188-195

  Sullivan, J S ^a   Le, M T ^b   Pan, Z ^c,d   Rivard, C ^b   Love Osborne, K ^a   Robbins, K ^a   Johnson, R J ^b   Sokol, R J ^a   Sundaram, S S ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Global Health and Health Disparities   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Breath hydrogen; hyperuricaemia; malabsorption; obesity

Indexed keywords

FRUCTOSE; GLUCOSE; HYDROGEN; INSULIN; URIC ACID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CARBOHYDRATE ABSORPTION; CARBOHYDRATE METABOLISM; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEN BREATH TEST; INSULIN BLOOD LEVEL; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION; BLOOD; BREATH ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; EATING; INSULIN RESISTANCE; METABOLISM; PREDICTIVE VALUE;

ADOLESCENT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BREATH TESTS; CHILD; EATING; FEMALE; FRUCTOSE; HUMANS; HYDROGEN; INSULIN; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; URIC ACID;

EID: 84988240385     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/ijpo.238     Document Type: Article

References (33)

1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C,. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393.
2. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993-999.
3. Nguyen S, Choi HK, Lustig RH, Hsu CY,. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009; 154: 807-813.
4. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism 2011; 60: 1259-1270.
5. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM,. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282: 1659-1664.
6. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1961-1971.
7. Van den Berghe G,. Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways. Prog Biochem Pharmacol 1986; 21: 1-32.
8. Walker RW, Le KA, Davis J, et al. High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans. J Am Coll Nutr 2012; 31: 369-374.
9. Beevers G, Lip GY, O'Brien E,. ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques. BMJ 2001; 322: 981-985.
10. Stirpe F, Della Corte E, Bonetti E, Abbondanza A, Abbati A, De Stefano F,. Fructose-induced hyperuricaemia. Lancet 1970; 2: 1310-1311.
11. Ishimoto T, Lanaspa MA, Le MT, et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A 2012; 109: 4320-4325.
12. Rao SS, Attaluri A, Anderson L, Stumbo P,. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5: 959-963.
13. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA,. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011; 53: 810-820.
14. Abdelmalek MF, Lazo M, Horska A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012; 56: 952-960.
15. Solga S, Alkhuraishe AR, Clark JM, et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 2004; 49: 1578-1583.
16. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N,. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918-924.
17. Shu R, David ES, Ferraris RP,. Luminal fructose modulates fructose transport and GLUT-5 expression in small intestine of weaning rats. Am J Physiol 1998; 274: G232-G239.
18. Paquot N, Schneiter P, Jequier E, et al. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects. Diabetologia 1996; 39: 580-586.
19. Macdonald I, Keyser A, Pacy D,. Some effects, in man, of varying the load of glucose, sucrose, fructose, or sorbitol on various metabolites in blood. Am J Clin Nutr 1978; 31: 1305-1311.
20. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH,. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010; 7: 251-264.
21. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L,. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005; 54: 1907-1913.
22. Jin R, Le NA, Liu S, et al. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab 2012; 97: E1088-E1098.
23. Kogut MD, Roe TF, Ng W, Nonnel GN,. Fructose-induced hyperuricemia: observations in normal children and in patients with hereditary fructose intolerance and galactosemia. Pediatr Res 1975; 9: 774-778.
24. Li Y, Xu C, Yu C, Xu L, Miao M,. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50: 1029-1034.
25. Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI,. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013; 62: 392-399.
26. Sartorio A, Del Col A, Agosti F, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007; 61: 877-883.
27. Vos MB, Colvin R, Belt P, et al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012; 54: 90-96.
28. Disse SC, Buelow A, Boedeker RH, et al. Reduced prevalence of obesity in children with primary fructose malabsorption: a multicentre, retrospective cohort study. Pediatr Obes 2013; 8: 255-258.
29. Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008; 138: 1452-1455.
30. Johner SA, Libuda L, Shi L, Retzlaff A, Joslowski G, Remer T,. Urinary fructose: a potential biomarker for dietary fructose intake in children. Eur J Clin Nutr 2010; 64: 1365-1370.
31. Weiser MM, Quill H, Isselbacher KJ,. Effects of diet on rat intestinal soluble hexokinase and fructokinase activities. Am J Physiol 1971; 221: 844-849.
32. Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS ONE 2012; 7: e47948.
33. Abdelmalek MF, Lazo M, Horska A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012; 56: 952-960.